Hudson Bay Capital Management’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-455,000
Closed -$3.06M 953
2023
Q3
$3.06M Sell
455,000
-142,500
-24% -$1.1M 0.02% 402
2023
Q2
$4.46M Sell
597,500
-262,500
-31% -$1.6M 0.03% 328
2023
Q1
$3.4M Sell
860,000
-50,000
-5% -$220K 0.03% 401
2022
Q4
$3.26M Buy
910,000
+70,000
+8% +$313K 0.03% 482
2022
Q3
$4.22M Sell
840,000
-30,000
-3% -$155K 0.04% 474
2022
Q2
$4.21M Buy
870,000
+323,700
+59% +$1.79M 0.03% 498
2022
Q1
$3.7M Buy
546,300
+146,300
+37% +$1.08M 0.05% 495
2021
Q4
$3.77M Buy
400,000
+185,015
+86% +$1.96M 0.04% 468
2021
Q3
$2.53M Buy
+214,985
New +$3.11M 0.03% 573

Other funds holding MOR

Hudson Bay Capital Management's MOR Position: Q4 2023 in Review

Hudson Bay Capital Management sold out of MorphoSys AG American Depositary Shares (MOR) in Q4 2023, closing a stake of 455,000 shares — an estimated $3.06M sold.

Hudson Bay Capital Management first reported a position in MOR in Q3 2021 and held it in 9 quarters. The position peaked at $4.46M in Q2 2023. 54 funds tracked by Wall St. Rank hold MOR as of Q4 2023.

  • Hudson Bay Capital Management reported no remaining MorphoSys AG American Depositary Shares position as of Q4 2023 after selling out during the quarter.
  • Hudson Bay Capital Management sold 455,000 MorphoSys AG American Depositary Shares shares in Q4 2023, an estimated $3.06M.
  • Hudson Bay Capital Management first reported a position in MorphoSys AG American Depositary Shares in Q3 2021 and held it in 9 quarters.
  • Hudson Bay Capital Management's MorphoSys AG American Depositary Shares position peaked at $4.46M in Q2 2023.
  • 54 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q4 2023.

Based on Hudson Bay Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.